EUVIMED · CrossrefJournal
JCO Precision Oncology
ISSN 2473-4284 · American Society of Clinical Oncology (ASCO)
Latest articles
Molecular Profiling for Precision Medicine in Adrenocortical Carcinoma: Real-World Data From the French Network ENDOCAN-COMETE
Urothelial Carcinoma in Lynch Syndrome: Clinical and Molecular Insights From a Large Multicenter Cohort
RESOLVE-IPD: Individual Patient Data Reconstruction and Uncertainty-Aware Subgroup Meta-Analysis
Fatal Capecitabine Toxicity Despite Negative Standard DPYD Screening in a Patient With Breast Cancer Harboring Hypomorphic Variants: A Case Report
Cancer Risks Associated With Germline BARD1 Pathogenic/Likely Pathogenic Variants: A Multicenter Study of 445 Families
Impact of Clonal Hematopoiesis on Outcomes in Metastatic Pancreatic Ductal Adenocarcinoma: Analysis From the PASS-01 Trial
Postresection Urinary Tumor DNA Refines Residual Disease Assessment and Recurrence Risk Stratification in Non–Muscle-Invasive Bladder Cancer
Osimertinib Toxicity Prompting Lazertinib Monotherapy: A Case Series
DLL3-Directed T-Cell Engagement With Tarlatamab in Immune Checkpoint Inhibitor–Refractory Metastatic Mucosal Melanoma
Longitudinal Pancreatic Imaging Findings in BRCA1 , BRCA2 , ATM, and PALB2 Heterozygotes Undergoing Pancreatic Cancer Surveillance: A Prospective PRECEDE Consortium Study
Redefining the EPCAM Phenotype: Deletion Architecture Determines Lynch Syndrome Cancer Risk
Assessment of the 2022 Constitutional Mismatch Repair Deficiency Syndrome Diagnostic Criteria Using the International Replication Repair Deficiency Consortium
Erratum: Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers
Pemigatinib in the Treatment of Metastatic, Inflammatory Triple-Negative Breast Cancer With FGFR2 Rearrangement: A Case Report and Review of the Literature
Integrated Methylation and Copy Number Analysis for Noninvasive Bladder Cancer Detection in Urine
APUC-6 Genes as a Potential Prognostic and Predictive Biomarker in the CHAARTED Prostate Cancer Trial
Performance and Clinical Benefit of Comprehensive Genomic Profiling of GI Tumors in a Comprehensive Cancer Center
Associations of Age With Tumor Genomic Characteristics in Relapsed/Refractory Cancers Interrogated With the NCI-MATCH Trial Targeted Gene Panel Assay
Using Disease-Agnostic Genomic Liquid Biopsy in Complex Diagnoses: Real-Life Example of cfChIP-Seq in a Fever of Unknown Origin
Evaluating the Prognostic Impact of IDH Mutations in Intrahepatic Cholangiocarcinoma
Identification of Predictive Biomarkers for Chemoradiotherapy Response in Rectal Cancer
Beyond the P Value: A Systematic Framework for Interpreting Oncology Clinical Trials
DPYD -Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: A Real-World Retrospective Study
Real-World Evidence for Oncology Patients With Rare NTRK Gene Fusions: Final Results From the German Multicenter Patient Cohort Study REALTRK
Fam-Trastuzumab Deruxtecan in Recurrent Low-Grade Serous Ovarian Carcinoma With CLU/NRG1 Fusion and Low Human Epidermal Growth Factor Receptor 2 Expression: A Case Report
Breast Neuroendocrine Carcinoma: Molecular Insights Beyond Histology
Real-World Genomic Characteristics and Prognostic Association in Advanced Papillary Thyroid Carcinoma
Integrated Radioproteomic Modeling for Early Recurrence Prediction and Metabolic Characterization in Hepatocellular Carcinoma
Cell-Free DNA Analysis With Clinicopathologic Factors for Early Detection and Refining Lymph Node Metastasis Risk in T1 Colorectal Cancer: Results From the COSMOS-CRC Study
Molecular Testing in Primary Advanced or Recurrent Endometrial Cancer: A Cost-Effectiveness Analysis
EUVIMED